Gene · 8607
Papers1,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation. | Cell Mol Gastroenterol Hepatol | 2023 | 36244648 | PubTator, text mining | PubMed |
| Genomic, epigenomic, and transcriptomic signatures for telomerase complex components: a pan-cancer analysis. | Mol Oncol | 2023 | 36239411 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers. | Clin Rev Allergy Immunol | 2023 | 35716254 | PubTator, text mining | PubMed |
| MS4A3-HSP27 target pathway reveals potential for haematopoietic disorder treatment in alimentary toxic aleukia. | Cell Biol Toxicol | 2023 | 34581912 | PubTator, text mining | PubMed |
| Direct cardiac reprogramming: Toward the era of multi-omics analysis. | Cell Insight | 2022 | 37193352 | PubTator, text mining | PubMed |
| Screening key genes related to neuropathic pain-induced depression through an integrative bioinformatics analysis. | Ann Transl Med | 2022 | 36660683 | PubTator, text mining | PubMed |
| Decoding Roles of Exosomal lncRNAs in Tumor-Immune Regulation and Therapeutic Potential. | Cancers (Basel) | 2022 | 36612282 | PubTator, text mining | PubMed |
| Intrinsic and Extrinsic Transcriptional Profiles That Affect the Clinical Response to PD-1 Inhibitors in Patients with Non-Small Cell Lung Cancer. | Cancers (Basel) | 2022 | 36612193 | PubTator, text mining | PubMed |
| Targets of histone H3 lysine 9 methyltransferases. | Front Cell Dev Biol | 2022 | 36568972 | PubTator, text mining | PubMed |
| Telomere Length: A Cardiovascular Biomarker and a Novel Therapeutic Target. | Int J Mol Sci | 2022 | 36555658 | PubTator, text mining | PubMed |
| Identification and verification of a novel epigenetic-related gene signature for predicting the prognosis of hepatocellular carcinoma. | Front Genet | 2022 | 36531219 | PubTator, text mining | PubMed |
| The conserved centrosomin motif, γTuNA, forms a dimer that directly activates microtubule nucleation by the γ-tubulin ring complex (γTuRC). | Elife | 2022 | 36515268 | PubTator, text mining | PubMed |
| Key Genetic Components of Fibrosis in Diabetic Nephropathy: An Updated Systematic Review and Meta-Analysis. | Int J Mol Sci | 2022 | 36499658 | PubTator, text mining | PubMed |
| Many Functions of Telomerase Components: Certainties, Doubts, and Inconsistencies. | Int J Mol Sci | 2022 | 36499514 | PubTator, text mining | PubMed |
| Canonical and Noncanonical ER Stress-Mediated Autophagy Is a Bite the Bullet in View of Cancer Therapy. | Cells | 2022 | 36497032 | PubTator, text mining | PubMed |
| Structural mechanism of extranucleosomal DNA readout by the INO80 complex. | Sci Adv | 2022 | 36490333 | PubTator, text mining | PubMed |
| Modulation of immunosuppressive cells and noncoding RNAs as immunotherapy in osteosarcoma. | Front Immunol | 2022 | 36457998 | PubTator, text mining | PubMed |
| Riluzole partially restores RNA polymerase III complex assembly in cells expressing the leukodystrophy-causative variant POLR3B R103H. | Mol Brain | 2022 | 36451185 | PubTator, text mining | PubMed |
| Hippocalcin-Like 1 blunts liver lipid metabolism to suppress tumorigenesis via directly targeting RUVBL1-mTOR signaling. | Theranostics | 2022 | 36438486 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8607/papers?page=10